Shanghai Ruiang Biotechnology
Developer of in-vitro diagnostic testing kits. The company focuses on the R&D, production, sales, and testing services of individualized molecular diagnostic reagents. The company provides accurate detection of genes and antigens for patients with hematological diseases, solid tumors, and infectious diseases. The main products are leukemia-associated fusion gene detection kit, immunoglobulin gene rearrangement…
Funding snapshot
About
Developer of in-vitro diagnostic testing kits. The company focuses on the R&D, production, sales, and testing services of individualized molecular diagnostic reagents. The company provides accurate detection of genes and antigens for patients with hematological diseases, solid tumors, and infectious diseases. The main products are leukemia-associated fusion gene detection kit, immunoglobulin gene rearrangement detection kit, human EGFR gene mutation detection kit, etc. Founded in 2014, headquart The company operates in Life Sciences > Genomics, Life Sciences > Life Sciences Platforms and Tools. Its business models include Genomics > Enabling Technologies > Kits and Reagents > Detection and Quantification, Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis. Founded in 2014. Headquartered in China, Shaoyang. The company has raised funding at the Series B stage. Backed by investors including ShenZhen GTJA Investment Group, CD Capital, Cathay Capital, Linkage Ventures.
Business model
Genomics > Enabling Technologies > Kits and Reagents > Detection and Quantification,
Life Sciences Platforms and Tools > Research Reagents and Kits > Genomics > Nucleic Acid Synthesis
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like Shanghai Ruiang Biotechnology?
Analyze your pitch deck before your next raise.
Analyze My Deck →